Results for "consumer data right"
541-550 of 652 results for 'consumer data right'
ASIC Corporate Governance Taskforce report; ASX listing rules update; ACCC cartel immunity and cooperation policy update; High Court considers financial assistance prohibition; and other corporate law developments
This Insight examines the latest developments in corporate law ...
ALRC's Discussion Paper released: a clearer, consistent and more rational framework for addressing corporate misconduct in Australia
The Australian Law Reform Commission released for consultation today a set of proposals aimed at overhauling the federal corporate criminal responsibility regime. This comes in the wake of criticisms that the current system is ineffective in preventing, deterring and prosecuting serious corporate crime. Whilst the reforms offer a clearer, consistent and more rational framework for addressing corporate misconduct in Australia, some elements (such as the adoption of a general 'associate' model for criminal attribution) will no doubt raise concern given their capacity to significantly extend corporate liability. We examine some of the key proposals and their likely impact. Partner Christopher Kerrigan and Senior Overseas Practitioner Cindy McNair report. ...
Dollars and sense: the evolution of executive remuneration practices
The need for robust executive remuneration frameworks is becoming increasingly important as companies tackle the challenges arising out of the COVID-19 pandemic, a heightened regulatory environment and the need to strike the right balance with executives to drive and reward conduct and performance t ...
Hydrogen is here - are you ready?
Following the release of the National Hydrogen Strategy in 2019, Australia is seeing exciting developments in government funding, new project announcements and private sector interest in a hydrogen industry. Federal and state governments are partnering with the private sector to support hydrogen technologies, in the race to become a premier exporter of clean hydrogen to the decarbonised global economy. This Insight explores the opportunities for Australia to establish a leading hydrogen industry, including recent policy developments, the latest funding announcements and key legal issues to be aware of. ...
Major proposed changes to FIRB regime
On 5 June 2020 the Federal Treasurer announced major proposed changes to Australia's FIRB regime to address national security risks and ensure greater compliance with FIRB approval conditions. ...
FIRB fee changes aimed at increasing affordable housing supply
On 10 December 2023, the Federal Government announced changes to the Foreign Investment Review Board residential land fee rules, designed to 'improve housing affordability and supply'. ...
High Court refuses liquidator special leave to appeal in unreasonable director-related transaction case
Last year, we published an Insight on a Federal Court decision where the plaintiff liquidator was successful in having a mortgage declared an unreasonable director-related transaction under s 588FDA o ...
Determining electricity generation prices: new regulations for projects participating in Vietnam's Wholesale Electricity Market
Recent changes to how prices are set for generators participating in Vietnam's wholesale power market reflect a broad policy shift away from bespoke structures for large-scale power plants (in particular foreign-invested BOT projects) and the government's determination to develop the merchant market ...
Reforms to strengthen and streamline the FIRB regime
On 1 May 2024, the Australian Treasurer announced reforms to the Foreign Investment Review Board (FIRB) framework, to make it stronger, more streamlined and more transparent. On the same day, the Government released an updated Foreign Investment Policy document, setting out the reforms. ...
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...


